Llwytho...

尼洛替尼与伊马替尼一线治疗初发慢性髓性白血病患者的比较研究

OBJECTIVE: To compare the cytogenetic and molecular responses, outcomes and severe hematologic toxicity of nilotinib and imatinib as frontline therapy in newly diagnosed patients with chronic myeloid leukemia in chronic phase(CML-CP). METHODS: Newly diagnosed CML-CP patients were consecutively recru...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Zhonghua Xue Ye Xue Za Zhi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Editorial office of Chinese Journal of Hematology 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342677/
https://ncbi.nlm.nih.gov/pubmed/32023729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.005
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!